Physician profile
John M Adams
NPI 1730191602
$4,465.55
in general payments reported to CMS, 2019-2025
11 companies · $2,455 in 2025
The $2,455 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $613 · 2021: $168 · 2022: $280 · 2023: $338 · 2024: $408 · 2025: $2,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,714 · Food and Beverage: $1,388 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,713.50 |
| Food and Beverage | $1,388.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,892.63 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $288.30 | 2023-2025 | Infuse, Btod |
| Alcon Vision LLC | $265.81 | 2019-2025 | Precision7, Precision 1 |
| Sun Pharmaceutical Industries INC. | $241.83 | 2019-2024 | |
| Oyster Point Pharma, INC. | $180.64 | 2022-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $153.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $128.78 | 2020-2023 | |
| Shire North American Group INC | $117.01 | 2019 | |
| Abb Con-Cise Optical Group LLC | $89.92 | 2021-2023 | Contact Lens, Spectacle Lenses |
| Allergan, INC. | $67.88 | 2022 | |
| Integra Lifesciences Corporation | $38.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.